RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All TITCK (Turkey) updates
TITCK (Turkey)
NOTICE
FARMAKOVİJİLANS İRTİBAT NOKTALARININ DİKKATİNE - 5402
Published: 11/9/2026Detected: 11/9/2026

Summary preview

Safety contact points for pharmacovigilance are being referenced/announced by TITCK, indicating that companies should ensure their pharmacovigilance communication channels are aligned with the notified information.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
safety
clinical
manufacturing
quality
labeling
#pharmacovigilance
#TİTCK
#safety reporting
#adverse events
#safety contact point

Official Source Document
Source Verified

Access the original document directly from TITCK.

View Official Document

More from TITCK (Turkey)

  • Kurum Başkanımızın 10 Kasım Atatürk'ü Anma Günü Mesajı - 162811/9/2026
  • Klinik Araştırma Taraflarının Dikkatine - 540111/9/2026
  • 2026 Temmuz Ayına Ait Mali Tablolar - 540011/9/2026
  • Klinik Araştırma Tarafların Dikkatine - 539911/6/2026
  • KYS-KLVZ-01 İletişim İşbirliği ve Bilgi Paylaşım Kılavuzunun Güncellenmesi - 539811/5/2026

Get TITCK (Turkey) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.